JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1982) 93, 11-16    DOI: 10.1677/joe.0.0930011
© 1982 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manni, A.
Right arrow Articles by Pearson, O. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Manni, A.
Right arrow Articles by Pearson, O. H.

Effect of high-dose oestrogen administration on the growth and prolactin receptor content of N-nitrosomethylurea-induced mammary tumours in the rat

Andrea Manni, John Rainieri, B. M. Arafah and O. H. Pearson

The effect of chronic administration of a high dose of oestradiol benzoate (OB) on growth and prolactin receptor content of the N-nitrosomethylurea (NMU)-induced rat mammary tumour was investigated. Daily i.m. administration of 50 µg OB for 8 days to tumour-bearing rats induced marked reduction in tumour size which was already significant after only three injections. Simultaneous daily administration of 1 mg perphenazine to stimulate endogenous prolactin release counteracted the inhibitory effect on tumour growth of OB but only partially since the tumours grew significantly more when perphenazine was injected alone. No treatment significantly affected prolactin receptor content in the tumours. We concluded that administration of pharmacological doses of OB has a potent antitumour action on the NMU-induced rat mammary tumour. This effect can only partially be explained by inhibition of the peripheral action of prolactin.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the Society for Endocrinology.